These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
810 related items for PubMed ID: 15170874
1. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia. McEvoy C, Bowling S, Williamson K, McGaw P, Durand M. Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874 [Abstract] [Full Text] [Related]
2. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Durand M, Sardesai S, McEvoy C. Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763 [Abstract] [Full Text] [Related]
3. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619 [Abstract] [Full Text] [Related]
4. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation. Durand M, Mendoza ME, Tantivit P, Kugelman A, McEvoy C. Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205 [Abstract] [Full Text] [Related]
5. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators. Pediatrics; 2007 Apr; 119(4):716-21. PubMed ID: 17403842 [Abstract] [Full Text] [Related]
6. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Gross SJ, Anbar RD, Mettelman BB. Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372 [Abstract] [Full Text] [Related]
7. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. Cummings JJ, D'Eugenio DB, Gross SJ. N Engl J Med; 1989 Jun 08; 320(23):1505-10. PubMed ID: 2657423 [Abstract] [Full Text] [Related]
8. Azithromycin in the extremely low birth weight infant for the prevention of bronchopulmonary dysplasia: a pilot study. Ballard HO, Anstead MI, Shook LA. Respir Res; 2007 Jun 05; 8(1):41. PubMed ID: 17550598 [Abstract] [Full Text] [Related]
9. Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone. Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S. Pediatr Pulmonol; 2003 May 05; 35(5):392-9. PubMed ID: 12687597 [Abstract] [Full Text] [Related]
11. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K, National Institutes of Child Health and Human Development Neonatal Research Network. Pediatrics; 2005 Dec 05; 116(6):1353-60. PubMed ID: 16322158 [Abstract] [Full Text] [Related]
15. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, Poole WK, NICHD Neonatal Research Network. Pediatrics; 2006 Jul 05; 118(1):e115-23. PubMed ID: 16818526 [Abstract] [Full Text] [Related]
19. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. Rozycki HJ, Byron PR, Elliott GR, Carroll T, Gutcher GR. Pediatr Pulmonol; 2003 May 05; 35(5):375-83. PubMed ID: 12687595 [Abstract] [Full Text] [Related]